Hematology TimesSusceptibility to 2nd cancers in WM/LPL survivorsApril 30, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLHodgkin LymphomaNon-Hodgkin LymphomaFollicular Lymphoma
Hematology TimesHL survivors have long-term risk of cardiovascular diseaseApril 28, 2015Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Hematology TimesPET scans could prevent unnecessary RT in HLApril 23, 2015Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Oncology PracticeABVD and Stanford V similar for bulky mediastinal Hodgkin’s lymphomaApril 20, 2015Lymphoma & Plasma Cell DisordersAggressive LymphomasHodgkin Lymphoma
Hematology TimesDrug produces ‘dramatic’ results in HLMarch 19, 2015Lymphoma & Plasma Cell DisordersTransplantationHodgkin Lymphoma
Oncology PracticeBrentuximab doubles PFS in Hodgkin’s lymphoma patientsMarch 18, 2015Lymphoma & Plasma Cell DisordersAggressive LymphomasHodgkin Lymphoma
Hematology TimesNew radiation guidelines for pediatric HLMarch 5, 2015Lymphoma & Plasma Cell DisordersPediatricsHodgkin Lymphoma
Hematology TimesCancer care spending doesn’t correlate to lives savedMarch 4, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersRelated IssuesHodgkin LymphomaNon-Hodgkin Lymphoma
Hematology TimesWhy EBV-positive lymphomas resist IFN therapyJanuary 28, 2015Lymphoma & Plasma Cell DisordersRelated IssuesHodgkin LymphomaNon-Hodgkin Lymphoma
Hematology TimesHIV doesn’t hinder lymphoma patients’ response to ASCTJanuary 7, 2015Lymphoma & Plasma Cell DisordersTransplantationHodgkin LymphomaNon-Hodgkin Lymphoma
Hematology TimesOlder patients benefit from brentuximab treatmentJanuary 6, 2015Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Hematology TimesClassic HL vulnerable to PD-1 blockade therapyDecember 24, 2014Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Hematology TimesBrentuximab combinations highly active in Hodgkin lymphomaDecember 19, 2014Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Hematology TimesPFS improvement will translate to OS, speaker saysDecember 9, 2014Lymphoma & Plasma Cell DisordersTransplantationHodgkin Lymphoma
Hematology NewsBrentuximab changes landscape for post-transplant Hodgkin’s lymphoma patientsDecember 7, 2014Rare DiseasesTransfusion MedicineAggressive LymphomasCellular TherapyHodgkin Lymphoma
